Teladoc Health Files 8-K on Officer Changes and Shareholder Votes

Ticker: TDOC · Form: 8-K · Filed: 2025-05-23T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, governance, shareholder-vote

Related Tickers: TDOC

TL;DR

Teladoc leadership shuffle and shareholder votes incoming - watch closely.

AI Summary

Teladoc Health, Inc. filed an 8-K on May 23, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders. The report date is May 22, 2025.

Why It Matters

This filing provides crucial updates on the company's leadership and governance, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: medium — Changes in directors or officers, and shareholder votes can signal shifts in company strategy or internal dynamics that may affect performance.

Key Players & Entities

FAQ

Who are the specific directors or officers departing from Teladoc Health, Inc.?

The filing indicates the departure of directors or certain officers but does not name them in the provided excerpt.

Were any new directors or officers appointed to Teladoc Health, Inc.?

Yes, the filing states the election of directors and appointment of certain officers as part of the reported items.

What specific compensatory arrangements for officers are detailed in this filing?

The filing mentions compensatory arrangements of certain officers but does not provide specific details in the excerpt.

What matters were submitted to a vote of security holders by Teladoc Health, Inc.?

The filing confirms the submission of matters to a vote of security holders, but the specific matters are not detailed in the provided text.

What is the primary jurisdiction of incorporation for Teladoc Health, Inc.?

Teladoc Health, Inc. is incorporated in Delaware.

From the Filing

0001477449-25-000063.txt : 20250523 0001477449-25-000063.hdr.sgml : 20250523 20250523160512 ACCESSION NUMBER: 0001477449-25-000063 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250522 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250523 DATE AS OF CHANGE: 20250523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 25982098 BUSINESS ADDRESS: STREET 1: 155 E 44TH STREET STREET 2: FLOOR 17 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 155 E 44TH STREET STREET 2: FLOOR 17 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 8-K 1 tdoc-20250522.htm 8-K tdoc-20250522 FALSE 0001477449 0001477449 2024-05-22 2024-05-22 0001477449 dei:FormerAddressMember 2024-05-22 2024-05-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 22, 2025 ___________________________________ Teladoc Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Delaware (State or other jurisdiction of incorporation) 001-37477 (Commission File Number) 04-3705970 (I.R.S. Employer Identification No.) 155 E 44th Street Floor 17 New York , NY 10017 (Address of principal executive offices and zip code) ( 203 ) 635-2002 (Registrant's telephone number, including area code) 2 Manhattanville Road , Suite 203 Purchase , NY 10577 (Former address) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common stock, par value $0.001 per share TDOC The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Teladoc Health, Inc. (the “Company”) was held on May 22, 2025. At the Annual Meeting, the Company’s stockholders a

View on Read The Filing